Scrutinize the data and tweets to envisage if the closing price of $nvs will swell or contract at 2015-09-30. Please affirm either Rise or Fall.
Context: date,open,high,low,close,adj-close,inc-5,inc-10,inc-15,inc-20,inc-25,inc-30
2015-09-16,-0.7,0.2,-1.0,1.4,1.4,-1.2,-1.8,-1.4,-0.9,0.3,1.1
2015-09-17,-0.9,1.0,-0.9,0.2,0.2,-1.1,-1.7,-1.5,-1.4,-0.1,0.7
2015-09-18,0.5,1.3,-0.2,-1.3,-1.3,0.2,-0.3,-0.3,-0.2,1.0,1.8
2015-09-21,1.7,1.8,-0.4,-0.8,-0.8,1.1,0.7,0.3,0.5,1.6,2.4
2015-09-22,0.6,0.9,-0.8,-3.2,-3.2,3.6,3.6,3.3,3.7,4.4,5.4
2015-09-23,0.5,0.7,-0.2,-0.5,-0.5,3.0,3.7,3.6,4.0,4.4,5.6
2015-09-24,0.5,0.7,-0.7,-0.7,-0.7,2.3,3.9,4.0,4.4,4.7,5.9
2015-09-25,2.8,3.0,-0.5,-0.5,-0.5,1.7,3.9,4.3,4.5,4.8,6.1
2015-09-28,3.1,3.1,-0.5,-1.6,-1.6,2.0,4.9,5.6,5.8,6.2,7.3
2015-09-29,-0.4,0.9,-0.7,-0.3,-0.3,1.6,4.5,5.5,5.7,6.3,7.2

2015-09-16: first patient dosed in mid-stage study of imetelstat in myelofibrosis  #premarket $jnj $gern $nvs
2015-09-24: #barclays on $halo#pathway for #enhanze-formulated #therapies shorter than expected$celg $gild $pfe $rhhby $nvs $ibb $xbi|novartis launches portfolio of drugs for low- and low-middle-income countries 
2015-09-25: pre-market gappers: $nke $emes $nvs $pir $cxrx $inap $blph $jbl $armh $bbry $finl
Answer:
Scrutinize the data and tweets to envisage if the closing price of $nvs will swell or contract at 2015-09-30. Please affirm either Rise or Fall.
Context: date,open,high,low,close,adj-close,inc-5,inc-10,inc-15,inc-20,inc-25,inc-30
2015-09-16,-0.7,0.2,-1.0,1.4,1.4,-1.2,-1.8,-1.4,-0.9,0.3,1.1
2015-09-17,-0.9,1.0,-0.9,0.2,0.2,-1.1,-1.7,-1.5,-1.4,-0.1,0.7
2015-09-18,0.5,1.3,-0.2,-1.3,-1.3,0.2,-0.3,-0.3,-0.2,1.0,1.8
2015-09-21,1.7,1.8,-0.4,-0.8,-0.8,1.1,0.7,0.3,0.5,1.6,2.4
2015-09-22,0.6,0.9,-0.8,-3.2,-3.2,3.6,3.6,3.3,3.7,4.4,5.4
2015-09-23,0.5,0.7,-0.2,-0.5,-0.5,3.0,3.7,3.6,4.0,4.4,5.6
2015-09-24,0.5,0.7,-0.7,-0.7,-0.7,2.3,3.9,4.0,4.4,4.7,5.9
2015-09-25,2.8,3.0,-0.5,-0.5,-0.5,1.7,3.9,4.3,4.5,4.8,6.1
2015-09-28,3.1,3.1,-0.5,-1.6,-1.6,2.0,4.9,5.6,5.8,6.2,7.3
2015-09-29,-0.4,0.9,-0.7,-0.3,-0.3,1.6,4.5,5.5,5.7,6.3,7.2

2015-09-16: first patient dosed in mid-stage study of imetelstat in myelofibrosis  #premarket $jnj $gern $nvs
2015-09-24: #barclays on $halo#pathway for #enhanze-formulated #therapies shorter than expected$celg $gild $pfe $rhhby $nvs $ibb $xbi|novartis launches portfolio of drugs for low- and low-middle-income countries 
2015-09-25: pre-market gappers: $nke $emes $nvs $pir $cxrx $inap $blph $jbl $armh $bbry $finl
Answer:+Rise